Impact of Antifungal Prophylaxis Continuation or Discontinuation After Allogeneic Hematopoietic Cell Transplant on the Incidence of Invasive Mold Infection.

Justine Abella RossBrian LeeHuiyan MaBernard Tegtmeier Deepa Nanayakkara Jana K Dickter Ricardo SpielbergerEileen SmithVinod A Pullarkat Stephen J Forman Randy A TaplitzRyotaro NakamuraMonzr M Al Malki Sanjeet Singh Dadwal

Published in: Open forum infectious diseases (2024)

There was no difference in probable IMI at day +100 after alloHCT based on continuing vs discontinuing AFPx at hospital discharge after alloHCT admission supporting a risk-adapted prophylaxis approach.

Keyphrases

bone marrow
stem cell transplantation
single cell
emergency department
candida albicans
cell therapy
risk factors
hematopoietic stem cell
medical education